[1]
F. A. Akkuş, “Factors associated with the efficacy of omalizumab treatment in chronic spontaneous urticaria”, Allergol Immunopathol, vol. 53, no. 2, pp. 1–7, Mar. 2025, doi: 10.15586/aei.v53i2.1207.